Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis.
Magdalena ChrabaszczAlbert StecMichał ZarembaCezary MaciejewskiLidia RudnickaMariusz SikoraPublished in: Clinical, cosmetic and investigational dermatology (2023)
Our findings suggest that copeptin may be a promising biomarker of microcirculation alterations in systemic sclerosis.